Bupivacaine Hcl

   
Google
 
Web NewDrugInformation.com

Bupivacaine Hcl


Drug - Bupivacaine Hcl
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Bupivacaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 0.75%
The potency of the active ingredient(s), Bupivacaine Hydrochloride. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Bupivacaine Hcl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 070585
The FDA assigned number to Bupivacaine Hcl. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Bupivacaine Hcl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 3, 1987
The date Bupivacaine Hcl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Bupivacaine Hcl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Bupivacaine Hcl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Bupivacaine Hcl.

Bupivacaine Hcl